Explaining diffusion patterns for complex health care innovations.

Jean-Louis Denis; Yann Hébert; Ann Langley; Daniel Lozeau; Louise-Hélène Trottier

doi:10.1097/00004010-200207000-00007

Home/Archive/PubMed

PubMed · 12146784

Explaining diffusion patterns for complex health care innovations.

Jean-Louis Denis·Yann Hébert·Ann Langley·Daniel Lozeau·Louise-Hélène Trottier

View original source ↗Export metadata ↓

Abstract

Why are some less solidly supported health care innovations widely adopted while others with apparently stronger scientific support remain underused? Drawing on four case studies, the authors argue that the way in which the distribution of benefits and risks map onto the interests, values, and power distribution of the adopting system is critical to understanding how innovations diffuse.

Explore related subjects

Cholecystectomy, Laparoscopic Decision Making Diffusion of Innovation Evidence-Based Medicine Filtration Health Services Research Heparin, Low-Molecular-Weight Humans Organizational Case Studies Organizational Innovation Power, Psychological Process Assessment, Health Care Renal Dialysis Risk Assessment Therapeutic Community Venous Thrombosis Journal Article Research Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Jean-Louis Denis, Yann Hébert, Ann Langley, Daniel Lozeau, Louise-Hélène Trottier. 2002. Explaining diffusion patterns for complex health care innovations.. https://doi.org/10.1097/00004010-200207000-00007

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

[Heterotopic pancreas in the gallbladder. Diagnosis, therapy, and course of a rare developmental anomaly of the pancreas].

Ectopic pancreas is a rare entity but the second most prevalent pancreatic anomaly. Heterotopic pancreas is defined as the presence of pancreatic tissue without any anatomic or vascular continuity with the main body of the pancreas. Its aetiology is not clearly established. In 1916, Poppi published for the first time evidence of heterotopic pancreas in the gallbladder. A review of the literature up to the present showed only 28 more cases worldwide of ectopic pancreas in the gallbladder. Aberrant pancreas is incidentally discovered in 2% of autopsies and has been estimated to occur once in every 500 upper abdominal explorations. Ninety per cent of ectopic pancreas is found in the stomach, duodenum, and jejunum. Mostly it is asymptomatic and benign. For this reason, therapy is indicated only in patients with symptoms such as pyloric obstruction, bleeding, and malignant transformation. Surgical resection or endoscopic mucosal resection as a newer method are recommended.

Cholecystectomy, Laparoscopic↗

PubMed2006

Gallbladder cancer.

Explore the source record for details and available documents.

Cholecystectomy, Laparoscopic↗

PubMed2006

[Laparoscopic cholecystectomy--a never-ending success story?].

Today, laparoscopic cholecystectomy is the most commonly used surgical laparoscopic intervention. The surgeon must familiarize himself with the patient's biliary anatomy using appropriate imaging techniques. Prior to the intervention, an esophago-gastro-duodenoscopy is performed to exclude a florid ulcer. The most serious complication is an unrecognized injury to the common bile or hepatic duct. Intra-operative bleeds can usually be managed endoscopically. If the pathologist diagnoses a gallbladder carcinoma the patient must undergo appropriate staging and a conventional revision procedure (removal of any metastases that might be present and resection of the gallbladder bed).

Cholecystectomy, Laparoscopic↗